These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA, BEAT-ROP Cooperative Group. JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848 [Abstract] [Full Text] [Related]
11. Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Chen YH, Chen SN, Lien RI, Shih CP, Chao AN, Chen KJ, Hwang YS, Wang NK, Chen YP, Lee KH, Chuang CC, Chen TL, Lai CC, Wu WC. Eye (Lond); 2014 Sep; 28(9):1080-6; quiz 1087. PubMed ID: 25104736 [Abstract] [Full Text] [Related]
14. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X, Li J, Hu X, Yu S, Pan J, Tang S. Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [Abstract] [Full Text] [Related]
18. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy. Kuo HK, Sun IT, Chung MY, Chen YH. Ophthalmologica; 2015 May; 234(4):211-7. PubMed ID: 26393895 [Abstract] [Full Text] [Related]